Erzofri on Blue Shield Rx Enhanced (S2468-004)
paliperidone palmitate
Covered, with prior authorization required.
Tier 4 (non-preferred drug). Quantity limit of 0.25 per 28 days.
$259.84
Patient pays / month
$779.51
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $702.26 for a month. Other covered strengths are listed below.
Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| ERZOFRI EXTENDED-RELEASE 117 mg/.75mL Injection | 5 | $686.70 | PA · 0.75 per 28 days |
| ERZOFRI EXTENDED-RELEASE 156 mg/mL Injection | 5 | $858.41 | PA · 1 per 28 days |
| ERZOFRI EXTENDED-RELEASE 234 mg/1.5mL Injection | 5 | $1,716.77 | PA · 1.5 per 28 days |
| ERZOFRI EXTENDED-RELEASE 351 mg/2.25mL Injection | 5 | $317.60 | PA · 4.5 per 365 days |
| ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection | 4 | $259.84 | PA · 0.25 per 28 days |
| ERZOFRI EXTENDED-RELEASE 78 mg/.5mL Injection | 5 | $463.51 | PA · 0.5 per 28 days |
Verify with the plan before prescribing or filling. Member services: (888)239-6469. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s2468-004